Skip to main content

Moore Duncan's Form 4 filing

ASP Isotopes Inc.ASPI · filed Apr 17, 2026

Accession no.
0001477932-26-002387
Filed
Apr 17, 2026
Trade date
Nov 12, 2025-Apr 16, 2026
Filing delay
156 daysLate
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions. Open-market sales total $60.7K. It was filed 156 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Moore DuncanCIK 0001888265Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 12, 2025Common StockAGrant or awardAcquired+25,469–F1–1,020,022Direct
Dec 18, 2025Common StockAGrant or awardAcquired+36,548–F2–1,056,570Direct
Apr 16, 2026Common StockSSaleDisposed−11,642$5.21F4−$60,654.821,044,928Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Award of shares of restricted stock in connection with the reporting person's service as an independent director of ASP Isotopes Inc. on the QLE Structuring and Strategic Transactions Committee.

Referenced by the price of 1 transaction in Table I.

F2

2025 annual award of shares of restricted stock in connection with the reporting person's service as an independent director of ASP Isotopes Inc.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.055 to $5.52, inclusive. The reporting person undertakes to provide ASP Isotopes Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)